Effects of Clinical Pilates on Pain and Quality of Life in Women With Dyspareunia

ConditionDyspareunia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-55
SponsorOkan University

About this trial

The aim of this study is to investigate the effects of clinical Pilates exercises on pain, self-esteem, body image, depression, and quality of life in women with dyspareunia. The study addresses dyspareunia as a multifaceted health problem with psychological, social as well as physical implications. it evaluates the effects of pelvic floor-focused clinical Pilates interventions on physiological symptoms and psychosocial well-being. it also demonstrates this approach as effective, safe, and evidence-based method in the treatment of dyspareunia among women in Turkish society.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Female participants aged 18-55 years

Sexually active

Willing to participate in the study

No communication problems

Disqualifiers

Having respiratory or neurological problems

Being pregnant

History of urogenital surgery

Trial design

Design model

Parallel

Treatments tested in this trial

  • Clinical Pilates Exercise

    Other intervention

    Pelvic Floor-Focused Clinical Pilates Exercises

Treatment groups

20 Participants
are divided into 2 treatment groups
Group A: Intervention Group (Clinical Pilates Exercises)Experimental treatment 1 intervention
Group B: Control GroupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Numeric Rating Scale (NRS)

The Numeric Rating Scale (NRS) is one of the most valid and reliable numerical scales used to assess an individual's pain intensity. Scores range from 0 to 10, with higher scores indicating greater pain intensity. A score of "0" represents "no pain," whereas "10" represents "the worst pain imaginable."\*\*

Time frame
Baseline and 8 weeks

Secondary outcomes

1

Female Sexual Function Index (FSFI)

The Female Sexual Function Index (FSFI) is a Likert-type scale consisting of 19 items that evaluates female sexual dysfunction over the past four weeks. The scale assesses six domains: sexual desire, arousal, lubrication, orgasm, satisfaction, and pain/discomfort. The maximum raw total score is 95 and the minimum is 4; after applying domain-specific weighting coefficients, the total score ranges from 2 to 36. The weighting factors used for scoring are 0.6 for desire; 0.3 for arousal and lubrication; and 0.4 for orgasm, satisfaction, and pain/discomfort. A total score below 26.55 is defined as indicative of sexual dysfunction. Higher scores indicate better sexual function.

Time frame
Baseline and 8 weeks
2

Carol Postpartum Sexual Function and Dyspareunia Assessment Scale

The Carol Postpartum Sexual Function and Dyspareunia Assessment Scale was developed to evaluate sexual function and the presence of dyspareunia in women who have resumed vaginal intercourse after vaginal delivery. The scale consists of a total of 11 items and classifies the severity of the disorder at different levels. The first seven items are rated using a five-point Likert scale: "never" (0 points), "almost never" (1 point), "sometimes" (2 points), "usually" (3 points), and "always" (4 points). The last four items assess pain intensity using a Numeric Rating Scale (NRS), with scores ranging from "no pain" (0 points) to "unbearable/maximum pain" (10 points).\*\*

Time frame
Baseline and 8 weeks
3

Short Form-36 (SF-36)

The Short Form-36 (SF-36) consists of 36 items and evaluates an individual's self-assessment across physical functioning, social functioning, role limitations (due to physical and emotional problems), mental health, vitality (energy), pain, and general perception of health. The assessment considers the previous four weeks. The SF-36 does not have absolute cutoff scores to define good or poor quality of life. However, according to commonly used classifications in the literature, scores are interpreted as follows: 80-100 indicates very good quality of life, 60-79 good, 40-59 moderate, and 0-39 poor quality of life.\*\*

Time frame
Baseline and 8 weeks
4

Beck Depression Inventory (BDI)

The Beck Depression Inventory (BDI) is a Likert-type scale developed by Beck to assess emotional, cognitive, and motivational components of depression. The scale evaluates symptoms over the past week and consists of 21 items. Each item has four response options ranging from 0 to 3. Total scores are interpreted as follows: 9 or below indicates "no depression," 10-16 indicates "mild depression," 17-23 indicates "moderate depression," and 24 or higher indicates "severe depression."\*\*

Time frame
Baseline and 8 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: